⌘K

Home/Filings/4/0001247741-05-000008

4//SEC Filing

CROSS ALEXANDER D 4

Accession 0001247741-05-000008

CIK 0000886163other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 2:00 PM ET

Size

5.7 KB

Accession

0001247741-05-000008

Insider Transaction Report

Form 4

Period: 2005-01-03

LIGAND PHARMACEUTICALS INCLGND

CROSS ALEXANDER D

Director

Transactions

Award
Non-Qualified Stock Option (right to buy)
2005-01-03+1,841→ 1,841 total
Exercise: $3.73From: 2005-01-31Exp: 2015-01-03→ Common Stock (1,841 underlying)

Footnotes (2)

[F1]The option becomes exercisable in twelve successive equal monthly installments upon completion of each calendar month of service beginning 1/31/05.
[F2]No price applies.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1

filerCIK 0001182619

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 2:00 PM ET
Size: 5.7 KB

View on SEC.gov